Andrius Žučenka - Concepedia

Author

Andrius Žučenka

Vilnius University ORCID

Also Known As

, A Zucenka, A Žucenka, A Žučenka, A. Zucenka, A. Žučenka, Andrius Zucenka, Andrius Žucenka, Andrius Žučenka

Publications

221

Citations

H-Index

Concepts

All Affiliations

Vilnius University Memorial Sloan Kettering Cancer Center Vilnius University Hospital Santariskiu Klinikos The University of Texas MD Anderson Cancer Center Emory University

AŽ

About

Andrius Žučenka is an author at Vilnius University specializing in oncology, hematology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	34
2	Health Sciences	1	1	23
3	Cellular Therapies	1	1	23
4	Marrow Transplantation	1	1	23
5	Pharmacology	1	1	11

Andrius Žučenka

Publications

140

Citations

H-Index

Page 1

	Year	Citations
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation Andrius Žučenka, Vilmantė Vaitekėnaitė, Kazimieras Maneikis, Bone Marrow Transplantation Hematological MalignancyCell TherapyTransplantationOncologyMarrow Transplantation	2021	23
Menin inhibition with revumenib for <i>NPM1</i>-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study Martha Arellano, Michael J. Thirman, John F. DiPersio, Blood	2025	23
Revumenib Maintenance Therapy Following Revumenib-Induced Remission and Transplant Andrius Žučenka, Ghayas C. Issa, Martha Arellano, Blood	2023	20
Oxidative phosphorylation inhibition induces anticancerous changes in therapy‐resistant–acute myeloid leukemia patient cells Aida Vitkevičienė, Vytautas Janulis, Andrius Žučenka, Molecular Carcinogenesis	2019	16
HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia Aida Vitkevičienė, Giedrė Skiauterytė, Andrius Žučenka, Journal of Oncology	2019	13
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax‐based salvage therapies Andrius Žučenka, Regina Pileckytė, Igoris Trociukas, European Journal Of Haematology	2020	13
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients Andrius Žučenka, Kazimieras Maneikis, Birute Pugaciute, Annals of Hematology Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyPharmacology	2021	11
Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) <i>KMT2Ar</i> Acute Leukemia Ibrahim Aldoss, Ghayas C. Issa, James S. Blachly, Blood	2024	11
The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies Justinas Daraškevičius, Vidmantas Petraitis, Linas Davainis, Journal of Fungi	2022	10

Page 1